ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION

PURPOSE: To compare the changes in retinal perfusion on ultra–wide-field fluorescein angiography with the changes in diabetic retinopathy lesions observed on ultra–wide-field fundus color photographs after 3 monthly anti–vascular endothelial growth factor injections. METHODS: Retrospective intervent...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnin, Sophie, Dupas, Bénédicte, Lavia, Carlo, Erginay, Ali, Dhundass, Myriam, Couturier, Aude, Gaudric, Alain, Tadayoni, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2019
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410966/
https://www.ncbi.nlm.nih.gov/pubmed/30664126
http://dx.doi.org/10.1097/IAE.0000000000002422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410966/
https://www.ncbi.nlm.nih.gov/pubmed/30664126
http://dx.doi.org/10.1097/IAE.0000000000002422

Ejemplares similares